By Chris Wack
Shares of Polyrizon were up 34% to $2.19 after the company said the U.S. Patent and Trademark Office published a national phase patent application by the company.
Shares of the Israel-based company, which launched its initial public offering in October, traded as high as $4.80 on Dec. 18.
The biotechnology company said the patent application is for two core platform technologies: Capture and Contain, a nasal blocker technology, and Trap and Target, designed for advanced nasal drug delivery.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 30, 2024 10:34 ET (15:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。